<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyCompanySummaryOutput xmlns:ns2="local" id="28355" name="GlaxoSmithKline plc"><Parent>GlaxoSmithKline plc</Parent><CountDrugsInDevelopment>379</CountDrugsInDevelopment><ActiveTAs><ActiveTA id="651">Cancer</ActiveTA><ActiveTA id="158">HIV infection</ActiveTA><ActiveTA id="1185">Chronic obstructive pulmonary disease</ActiveTA><ActiveTA id="191">Influenza virus infection</ActiveTA><ActiveTA id="31">Asthma</ActiveTA><ActiveTA id="152">Hepatitis B virus infection</ActiveTA><ActiveTA id="188">Inflammatory disease</ActiveTA><ActiveTA id="291">Rheumatoid arthritis</ActiveTA><ActiveTA id="221">Mycobacterium tuberculosis infection</ActiveTA><ActiveTA id="40">Bacterial infection</ActiveTA></ActiveTAs><Website>https://www.gsk.com/</Website></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyCompanySummaryOutput>